This extensive investigation analyzed data from over 54,000 adolescents, drawn from the nationally representative Korea Youth Risk Behavior Web-based Survey (KYRBS). Such a robust sample size lends significant weight to the findings and marks one of the largest population-level surveys on adolescent mental health during COVID-19 to date. By focusing on tangible lifestyle modifications, including physical activity, dietary habits, and substance use, the research captures a multi-dimensional picture of behavioral impact on depression amid an extraordinary social context.

At the heart of the study lies an assessment of four key lifestyle factors that adolescents altered during the pandemic: an increase in physical activity, greater frequency of breakfast consumption, reduced alcohol use, and decreased smoking. Utilizing multinomial logistic regression analyses, researchers deciphered how these changes correlated with the self-reported decrease in depressive mood. Remarkably, every one of these healthier behavior shifts was strongly linked to positive mental health outcomes, underscoring the vital role of lifestyle even in crisis conditions.

Physical activity emerged as a powerful buffer against depression, with those who increased their exercise levels exhibiting more than twice the odds of alleviating depressive symptoms. This finding echoes a growing body of neuropsychiatric evidence pointing to exercise-induced neurogenesis and endorphin release as potent mood enhancers. In the constrained environment of the pandemic, where opportunities for structured social interactions were curtailed, physical activity provided a critical outlet for stress relief and emotional stabilization among adolescents.

Similarly, regular breakfast consumption showed a meaningful connection to improved mood states. Given the integral role of nutrition in brain function and hormonal regulation, it’s plausible that consistent morning meals contributed to better energy balance and cognitive resilience. The pandemic environment, rife with stress and disrupted routines, likely made maintaining such healthy dietary patterns especially challenging yet notably impactful on mental well-being.

The reduction in alcohol consumption was even more striking in its association with reduced depressive symptoms, revealing an over threefold increase in the odds of mood improvement. This highlights the hazardous relationship between substance use and adolescent mental health, an interaction that the pandemic may have exacerbated through increased anxiety and isolation. The findings imply that curtailed drinking – potentially driven by diminished social settings or enhanced familial supervision – acted as a protective factor during this sensitive period.

The most robust link was observed with decreased smoking, which showed an astounding sevenfold increased likelihood of depressive symptom reduction. This dramatic association underscores nicotine’s complex influence on adolescent neurochemistry and affect regulation. Smoking cessation or reduction changes may have contributed heavily to emotional relief, potentially modulating pathways involving dopamine and stress hormones that underpin depressive experiences.

Accounting for a plethora of confounding variables, the researchers confirmed that these associations remained both statistically significant and resilient across diverse demographic and psychosocial backgrounds. Such robustness strengthens the causal argument that lifestyle behavior modifications are not mere correlated phenomena but actively shape adolescent mental health trajectories during crises like COVID-19.

Beyond the statistical sphere, the study calls attention to broader societal implications. It advocates for public health policies that foster environments conducive to healthy habits, particularly during periods of turmoil. Suggested measures include reducing household-level stressors and amplifying social support networks, both pivotal in enabling adolescents to adopt and sustain beneficial behaviors. Moreover, the research emphasizes the urgent need for accessible mental health resources such as teletherapy and digital interventions tailored for youth.

The findings of this Korean dataset resonate globally, emphasizing universal truths about the interplay between behavior and mood. In pandemic contexts where physical and social restrictions exacerbate vulnerabilities, engaging in protective lifestyle adaptations emerges as a beacon of hope. By promoting physical exercise, nutritional regularity, and substance use avoidance, health authorities can empower the younger generation to navigate the psychological complexities of prolonged societal disruption more effectively.

This study also pioneers an integrative approach by combining epidemiological techniques with mental health assessment tools during an ongoing crisis, setting methodological standards for future inquiries worldwide. The scale and rigor of the research provide a blueprint for leveraging big data in mental health surveillance and intervention design, especially in adolescent populations where early prevention is critical.

In conclusion, the Korean research offers compelling evidence reinforcing that positive lifestyle changes have a measurable, beneficial impact on reducing depressive symptoms among adolescents in the throes of the COVID-19 pandemic. It spotlights the dynamic potential of individual and collective action in safeguarding mental health against a backdrop of global uncertainty, inviting stakeholders at every level to invest in strategies that bolster healthy behaviors for lasting psychological resilience.

As society emerges from the acute phases of the pandemic, the lessons unearthed by this study remain profoundly relevant. Supporting adolescents in embedding these lifestyle habits into their daily routines could have long-term benefits beyond the current crisis, potentially curbing the trajectory of mental health disorders that often manifest during youth. This research therefore not only contributes critical knowledge pertaining to COVID-19 but also enriches the broader fight against adolescent depression on a global scale.

Subject of Research: The association between lifestyle behavior modifications and depressive symptoms in Korean adolescents during the COVID-19 pandemic.

Article Title: Exploring the relationship between lifestyle factors and depressive symptoms in Korean adolescents amid the COVID-19 pandemic.

Article References:
Lee, Y., Jang, E., Park, S. et al. Exploring the relationship between lifestyle factors and depressive symptoms in Korean adolescents amid the COVID-19 pandemic. BMC Psychiatry 25, 844 (2025). https://doi.org/10.1186/s12888-025-06988-w

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-06988-w

The investigation, spearheaded by research associate professor Philip Veliz from the University of Michigan’s School of Nursing, meticulously analyzed data spanning from 2005 to 2023. These data were drawn from the Monitoring the Future Study, a robust, longitudinal annual survey tracking substance use among 8th, 10th, and 12th-grade students. The study’s design allowed for a granular assessment of lifetime medical and nonmedical stimulant use, providing representative insight into evolving patterns amid shifting prescribing practices and societal attitudes.

Medical use of prescription stimulants to manage ADHD symptoms among adolescents showed a slight uptick throughout the studied period, consistent with broader national trends in diagnosis and treatment. Despite this increase in medically supervised use, the crux of the investigation was the fate of nonmedical consumption – usage without prescription or for recreational effects – which the study found to have declined from 10% lifetime prevalence in 2005 down to 6% in 2023. This reduction is particularly striking against the backdrop of rising stimulant availability.

This trend reversal holds significant public health implications. While initial expectations might have predicted a parallel surge in nonmedical use accompanying increased medical prescriptions, the data suggest that adolescent misuse has not only stabilized but diminished substantially. Veliz emphasizes that this development aligns with the hopes of parents and clinicians eager to see controlled prescription use without corresponding misuse escalation, highlighting the effectiveness of nuanced intervention strategies.

Certainty regarding this downward trajectory is strengthened by the consistency of lifetime medical use prevalence, which remained around 8% in both 2005 and 2023. This steadiness, paired with a mild increase in current use, indicates that while more adolescents are responsibly benefitting from stimulants under healthcare supervision, fewer are engaging in unauthorized or recreational use. Such findings challenge the narrative that medical accessibility inevitably fuels misuse, suggesting instead that the two phenomena can diverge significantly with proper public health frameworks.

Researchers posit that several intersecting factors may be driving these positive developments. Enhanced public health messaging targeting the dangers of prescription stimulant misuse, refined prescribing guidelines emphasizing cautious and individualized treatment, and temporary shortages of stimulant medications have all likely contributed to the contraction in nonmedical adolescent use. These factors collectively paint a picture of a healthcare ecosystem progressively better equipped to balance therapeutic access against abuse potential.

Supporting this interpretation is the pattern observed in broader prescription drug misuse trends. Similar declines in nonmedical use have been documented for other controlled substances, including opioids and benzodiazepines, among youth populations. This suggests systemic shifts in both medical practice and cultural perceptions towards prescription drug safety and misuse deterrence, likely reinforced by increased regulatory scrutiny and educational outreach.

The study’s methodological rigor and longitudinal scope provide a compelling evidence base for clinicians and policymakers weighing the risks and benefits associated with stimulant medications. Understanding that medical use and misuse can follow distinct trajectories enables the development of tailored strategies focused on maximizing treatment efficacy while minimizing abuse. Such nuance is essential amid ongoing debates about ADHD diagnosis rates and prescription practices.

Co-authors of the research include notable scholars from multiple institutions, including Sean Esteban McCabe, Vita McCabe, John Jardine from the University of Michigan, Ty Schepis from Texas State University, Emily Pasman from the University of Illinois Chicago, and Timothy Wilens from Massachusetts General Hospital. This collaborative academic effort underscores the interdisciplinary importance of the issue, combining epidemiological, clinical, and pharmacological expertise.

Published in the prestigious Journal of the American Medical Association (JAMA) on July 29, 2025, the study was financially supported by the National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration (FDA). Their investment reflects the critical priority placed on understanding and addressing adolescent substance use as part of broader public health initiatives.

In conclusion, this investigation articulates a cautiously optimistic narrative in adolescent stimulant use dynamics. As prescription rates climb modestly, concurrent declines in misuse reveal the promise of effective public health interventions and evolving clinical practices. These insights pave the way for informed policymaking that safeguards adolescent well-being while ensuring access to needed ADHD treatments, situating the findings at the forefront of contemporary pharmacological research and health policy discourse.

Subject of Research: Patterns of medical and nonmedical use of prescription stimulants among U.S. adolescents
Article Title: Nonmedical use of prescription ADHD drugs among teens has dropped
News Publication Date: 29-Jul-2025
Web References: https://jamanetwork.com/journals/jama/article-abstract/2836875
References: Veliz P, McCabe SE, McCabe V, Jardine J, Schepis T, Pasman E, Wilens T. Trends in Medical and Nonmedical Use of Prescription Stimulants Among US Adolescents. JAMA. 2025; DOI: 10.1001/jama.2025.11260
Keywords: Health and medicine, Drug studies, Illicit drugs, Stimulants, Antihypertensive activity, Adolescents